60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.635
+0.085 (5.48%)
Oct 9, 2025, 4:00 PM EDT - Market closed

SXTP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
0.980.680.250.51
Revenue Growth (YoY)
128.70%168.70%-50.40%-
Cost of Revenue
0.350.380.470.43
Gross Profit
0.630.3-0.220.08
Selling, General & Admin
6.125.024.241.3
Research & Development
2.214.990.690.53
Total Operating Expenses
8.3310.014.931.83
Operating Income
-7.7-9.71-5.15-1.75
Interest Expense
-0.01-0.01-2.29-3.99
Other Non-Operating Income (Expense)
-0.121.773.63-0.44
Total Non-Operating Income (Expense)
-0.121.761.34-4.43
Pretax Income
-7.82-7.96-3.81-6.18
Provision for Income Taxes
0000
Net Income
-7.82-8.43-3.92-6.18
Minority Interest in Earnings
-0.01-0.01-0.050
Net Income Attributable to Preferred Dividends
-0.480.22-
Net Income to Common
-7.82-8.43-3.92-6.18
Shares Outstanding (Basic)
1000
Shares Outstanding (Diluted)
1000
Shares Change (YoY)
651.95%585.50%68.05%-
EPS (Basic)
-2.07-18.55-59.18-156.60
EPS (Diluted)
-2.07-18.55-59.18-156.60
Free Cash Flow
-6.37-5.75-4.6-1.01
Free Cash Flow Per Share
-6.06-12.65-69.37-25.59
Gross Margin
64.14%43.53%-87.15%15.42%
Operating Margin
-782.07%-1425.85%-2032.78%-342.41%
Profit Margin
-794.48%-1167.64%-1504.02%-1208.46%
FCF Margin
-646.72%-844.19%-1814.28%-197.57%
EBITDA
-7.63-9.65-5.05-1.67
EBITDA Margin
-775.26%-1416.49%-1993.20%-327.00%
EBIT
-7.7-9.71-5.15-1.75
EBIT Margin
-782.07%-1425.85%-2032.78%-342.41%
Effective Tax Rate
-0.02%-0.00%-0.01%-0.01%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q